Tryptanthrin induces growth inhibition and neuronal differentiation in the human neuroblastoma LA-N-1 cells

Chemico-Biological Interactions

Volumn 203, Issue 2, 2013, Pages 512-521

  Liao, Xuemei ^a   Leung, Kwok Nam ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cell cycle; Human neuroblastoma; N myc oncogene; Neuronal differentiation; Tryptanthrin

Indexed keywords

ACETYLCHOLINESTERASE; ANTINEOPLASTIC AGENT; MESSENGER RNA; MYC PROTEIN; SMALL INTERFERING RNA; TRYPTANTHRIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL CYCLE G0 PHASE; COLONY FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVITY; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; NERVE CELL DIFFERENTIATION; NEUROBLASTOMA; ONCOGENE MYC; PROTEIN EXPRESSION; UPREGULATION;

ANTINEOPLASTIC AGENTS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; G0 PHASE; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM INVASIVENESS; NEUROBLASTOMA; NEURONS; PROTO-ONCOGENE PROTEINS C-MYC; QUINAZOLINES; TUMOR MARKERS, BIOLOGICAL;

EID: 84875969300     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2013.03.001     Document Type: Article

References (44)

1. J.A. Marchal, F. Rodriguez-Serrano, J. Campos, R. Madeddu, H. Boulaiz, A. Martinez-Amat, E. Carrillo, O. Caba, J.C. Prados, C. Velez, C. Melguizo, A. Montella, and A. Aranega Differentiation: an encouraging approach to anticancer therapy Ital. J. Anat. Embryol. 111 1 2006 45 64
2. J.R. Park, A. Eggert, and H. Caron Neuroblastoma: biology, prognosis, and treatment Hematol. Oncol. Clin. North Am. 24 1 2010 65 86
3. F. Bourdeaut, D. Trochet, I. Janoueix-Lerosey, A. Ribeiro, A. Deville, C. Coz, J.F. Michiels, S. Lyonnet, J. Amiel, and O. Delattre Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma Cancer Lett. 228 1-2 2005 51 58
4. M. Hughes, H.B. Marsden, and M.K. Palmer Histologic patterns of neuroblastoma related to prognosis and clinical staging Cancer 34 5 1974 1706 1711
5. G. Han, B. Chang, M.J. Connor, and N. Sidell Enhanced potency of 9-cis versus all-trans-retinoic acid to induce the differentiation of human neuroblastoma cells Differentiation 59 1 1995 61 69
6. W. Spinelli, K.H. Sonnenfeld, and D.N. Ishii Effects of phorbol ester tumor promoters and nerve growth factor on neurite outgrowth in cultured human neuroblastoma cells Cancer Res. 42 12 1982 5067 5073
7. H.T. Rupniak, G. Rein, J.F. Powell, T.A. Ryder, S. Carson, S. Povey, and B.T. Hill Characteristics of a new human neuroblastoma cell line which differentiates in response to cyclic adenosine 3′:5′-monophosphate Cancer Res. 44 6 1984 2600 2607
8. H. Watanabe, T. Chisaka, T. Higuchi, A. Tanaka, Y. Horii, T. Sugimoto, and J. Imanishi Effect of human interferons on morphological differentiation and suppression of N-myc gene expression in human neuroblastoma cells Jpn. J. Cancer Res. 80 11 1989 1072 1076
9. A. Borriello, R. Roberto, F. Della Ragione, and A. Iolascon Proliferate and survive: cell division cycle and apoptosis in human neuroblastoma Haematologica 87 2 2002 196 214
10. W. Lutz, M. Stohr, J. Schurmann, A. Wenzel, A. Lohr, and M. Schwab Conditional expression of N-myc in human neuroblastoma cells increases expression of alpha-prothymosin and ornithine decarboxylase and accelerates progression into S-phase early after mitogenic stimulation of quiescent cells Oncogene 13 4 1996 803 812
11. F.A. Peverali, D. Orioli, L. Tonon, P. Ciana, G. Bunone, M. Negri, and G. Della-Valle Retinoic acid-induced growth arrest and differentiation of neuroblastoma cells are counteracted by N-myc and enhanced by max overexpressions Oncogene 12 2 1996 457 462
12. A. Negroni, S. Scarpa, A. Romeo, S. Ferrari, A. Modesti, and G. Raschella Decrease of proliferation rate and induction of differentiation by a MYCN antisense DNA oligomer in a human neuroblastoma cell line Cell Growth Differ. 2 10 1991 511 518
13. G. Honda, M. Tabata, and M. Tsuda The antimicrobial specificity of tryptanthrin Planta Med. 37 2 1979 172 174
14. Y.K. Lin, Y.L. Leu, T.H. Huang, Y.H. Wu, P.J. Chung, J.H.S. Pang, and T.L. Hwang Anti-inflammatory effects of the extract of indigo naturalis in human neutrophils J. Ethnopharmacol. 125 1 2009 51 58
15. M.C. Recio, M. Cerda-Nicolas, O. Potterat, M. Hamburger, and J.L. Rios Anti-inflammatory and antiallergic activity in vivo of lipophilic Isatis tinctoria extracts and tryptanthrin Planta Med. 72 6 2006 539 546
16. T. Kimoto, K. Hino, S. Koya-Miyata, Y. Yamamoto, M. Takeuchi, Y. Nishizaki, M.J. Micallef, S. Ushio, K. Iwaki, M. Ikeda, and M. Kurimoto Cell differentiation and apoptosis of monocytic and promyelocytic leukemia cells (U-937 and HL-60) by tryptanthrin, an active ingredient of Polygonum tinctorium Lour Pathol. Int. 51 5 2001 315 325
17. S.T. Yu, T.M. Chen, S.Y. Tseng, and Y.H. Chen Tryptanthrin inhibits MDR1 and reverses doxorubicin resistance in breast cancer cells Biochem. Biophys. Res. Commun. 358 1 2007 79 84
18. D. Schrenk, D. Riebniger, M. Till, S. Vetter, and H.P. Fiedler Tryptanthrins: a novel class of agonists of the aryl hydrocarbon receptor Biochem. Pharmacol. 54 1 1997 165 171
19. A. Edsjo, H. Nilsson, J. Vandesompele, J. Karlsson, F. Pattyn, L.A. Culp, F. Speleman, and S. Pahlman Neuroblastoma cells with overexpressed MYCN retain their capacity to undergo neuronal differentiation Lab. Invest. 84 4 2004 406 417
20. R.C. Seeger, S.A. Rayner, A. Banerjee, H. Chung, W.E. Laug, H.B. Neustein, and W.F. Benedict Morphology, growth, chromosomal pattern and fibrinolytic activity of two new human neuroblastoma cell lines Cancer Res. 37 5 1977 1364 1371
21. S. Engler, C. Thiel, K. Forster, K. David, R. Bredehorst, and H. Juhl A novel metastatic animal model reflecting the clinical appearance of human neuroblastoma: growth arrest of orthotopic tumors by natural, cytotoxic human immunoglobulin M antibodies Cancer Res. 61 7 2001 2968 2973
22. D. Opel, I. Naumann, M. Schneider, D. Bertele, K.M. Debatin, and S. Fulda Targeting aberrant PI3K/Akt activation by PI103 restores sensitivity to TRAIL-induced apoptosis in neuroblastoma Clin. Cancer Res. 17 10 2011 3233 3247
23. I. Janoueix-Lerosey, G. Schleiermacher, E. Michels, V. Mosseri, A. Ribeiro, D. Lequin, J. Vermeulen, J. Couturier, M. Peuchmaur, A. Valent, D. Plantaz, H. Rubie, D. Valteau-Couanet, C. Thomas, V. Combaret, R. Rousseau, A. Eggert, J. Michon, F. Speleman, and O. Delattre Overall genomic pattern is a predictor of outcome in neuroblastoma J. Clin. Oncol. 27 7 2009 1026 1033
24. V.H. Freedman, and S.I. Shin Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium Cell 3 4 1974 355 359
25. J. Harkins, M. Arsenault, K. Schlesinger, and J. Kates Induction of neuronal functions: acetylcholine-induced acetylcholinesterase activity in mouse neuroblastoma cells Proc. Natl. Acad. Sci. USA 69 11 1972 3161 3164
26. J.R. Kates, R. Winterton, and K. Schlessinger Induction of acetylcholinesterase activity in mouse neuroblastoma tissue culture cells Nature 229 5283 1971 345 347
27. D.O. Stram, K.K. Matthay, M. O'Leary, C.P. Reynolds, G.M. Haase, J.B. Atkinson, G.M. Brodeur, and R.C. Seeger Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent children's cancer group studies J. Clin. Oncol. 14 9 1996 2417 2426
28. S. Di Loreto, B. D'Angelo, M.A. D'Amico, E. Benedetti, L. Cristiano, B. Cinque, M.G. Cifone, M.P. Ceru, C. Festuccia, and A. Cimini PPAR beta agonists trigger neuronal differentiation in the human neuroblastoma cell line SH-SY5Y J. Cell. Physiol. 211 3 2007 837 847
29. T. Nakayama, S. Asami, S. Ono, M. Miura, M. Hayasaka, Y. Yoshida, M. Toriyama, S. Motohashi, and T. Suzuki Effect of cell differentiation for neuroblastoma by vitamin K analogs Jpn. J. Clin. Oncol. 39 4 2009 251 259
30. H.L. Chan, H.Y. Yip, N.K. Mak, and K.N. Leung Modulatory effects and action mechanisms of tryptanthrin on murine myeloid leukemia cells Cell. Mol. Immunol. 6 5 2009 335 342
31. L.I. Benowitz, and A. Routtenberg GAP-43: an intrinsic determinant of neuronal development and plasticity Trends Neurosci. 20 2 1997 84 91
32. L.H. Aarts, P. Schotman, J. Verhaagen, L.H. Schrama, and W.H. Gispen The role of the neural growth associated protein B-50/GAP-43 in morphogenesis Adv. Exp. Med. Biol. 446 1998 85 106
33. R.W. Shin, T. Iwaki, T. Kitamoto, and J. Tateishi Hydrated autoclave pretreatment enhances tau immunoreactivity in formalin-fixed normal and Alzheimer's disease brain tissues Lab. Invest. 64 5 1991 693 702
34. M.G. Rosenfeld, J.J. Mermod, S.G. Amara, L.W. Swanson, P.E. Sawchenko, J. Rivier, W.W. Vale, and R.M. Evans Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing Nature 304 5922 1983 129 135
35. S.D. Brain, T.J. Williams, J.R. Tippins, H.R. Morris, and I. MacIntyre Calcitonin gene-related peptide is a potent vasodilator Nature 313 5997 1985 54 56
36. J. McCulloch, R. Uddman, T.A. Kingman, and L. Edvinsson Calcitonin gene-related peptide: functional role in cerebrovascular regulation Proc. Natl. Acad. Sci. USA 83 15 1986 5731 5735
37. P. Kogner, P. Borgstrom, P. Bjellerup, F.H. Schilling, E. Refai, C. Jonsson, C. Dominici, E. Wassberg, H. Bihl, H. Jacobsson, E. Theodorsson, and M. Hassan Somatostatin in neuroblastoma and ganglioneuroma Eur. J. Cancer 33 12 1997 2084 2089
38. R.K.H. Liem, S.H. Yen, G.D. Salomon, and M.L. Shelanski Intermediate filaments in nervous tissues J. Cell Biol. 79 3 1978 637 645
39. N.B. Laferriere, T.H. MacRae, and D.L. Brown Tubulin synthesis and assembly in differentiating neurons Biochem. Cell Biol. 75 2 1997 103 117
40. A. Pession, and R. Tonelli The MYCN oncogene as a specific and selective drug target for peripheral and central nervous system tumors Curr. Cancer Drug Targets 5 4 2005 273 283
41. E. Bogenmann, M. Torres, and H. Matsushima Constitutive N-myc gene expression inhibits trkA mediated neuronal differentiation Oncogene 10 10 1995 1915 1925
42. M.L. Schmidt, H.R. Salwen, C.F. Manohar, N. Ikegaki, and S.L. Cohn The biological effects of antisense N-myc expression in human neuroblastoma Cell Growth Differ. 5 2 1994 171 178
43. L.A. Goodman, B.C. Liu, C.J. Thiele, M.L. Schmidt, S.L. Cohn, J.M. Yamashiro, D.S. Pai, N. Ikegaki, and R.K. Wada Modulation of N-myc expression alters the invasiveness of neuroblastoma Clin. Exp. Metast. 15 2 1997 130 139
44. K. Nara, T. Kusafuka, A. Yoneda, T. Oue, S. Sangkhathat, and M. Fukuzawa Silencing of MYCN by RNA interference induces growth inhibition, apoptotic activity and cell differentiation in a neuroblastoma cell line with MYCN amplification Int. J. Oncol. 30 5 2007 1189 1196